Rebirth of the Financial Crisis Sweeping the World

  Chapter 470, a turnover of nearly $90 billion!

  At present, Wang Guanxi’s No. 1 fund has a debt of 5.5 billion U.S. dollars, and his No. 2 fund has a debt of 1.2 billion U.S. dollars. The total debt is 6.7 billion U.S. dollars.

  However, the acquisition of Cardinal Health Group this time allowed Wang Guanxi’s consortium to reach out to the US pharmaceutical industry.

  The American Cardinal Health Group is actually a global top 100 company, a multinational group specializing in the global sales of health nutrition, health food research, production and medical health.

  Founded in 1971, Cardinal International Group is now a supplier of 90% of hospital medicines and nutritional foods in the United States.

  Now the world’s top scientific academies in the field of healthy and nutritious food and biology have conducted extensive technical cooperation with world-renowned international biologists, and developed a new generation of health and nutrition series that is world-renowned and has an internationally leading level. And using the world's most advanced biological gene purification technology, the maximum preservation of the activity of extracting nutrients.

  The series products of the Group have established sales outlets in more than 100 countries and regions around the world, mainly including the United States, European Union countries, Canada, Japan Benzene, Singapore, etc..

  The entire group has a very experienced work team.

  Now there are 1,800 pharmacies, 550 medical staff and consulting staff.

  The company’s medical consultants use the company’s strong financial base to engage in more than 1,600 researches in more than 200 medical fields. The company has cooperation with 2,900 hospitals, other medical institutions, retail pharmacies, and pharmaceutical manufacturers. With Dublin and Ohio as the center, branches have been opened on five continents.

Moreover, the group's products have won the highest international quality evaluation, the world's largest manufacturer and seller of nutrition and health products; the global sales champion, with a turnover of 56.9 billion U.S. dollars in 2004; the global market share of nutrition and health products reaches 40%; it is awarded AAAAA+ 1 The highest international credit rating; it has the world's largest nutritional product research and development center and more than 1,000 scientists who specialize in product research and development, of which more than half have doctoral degrees.

  Now it belongs to Wang Guanxi.

  Luo Baowen brought the financial statement.

  "BOSS, this is the balance sheet of Cardinal Health Group"

   "Well, I'll take a good look." Wang Guanxi took a closer look.

  Total current assets are 14.276 billion US dollars

   Total non-current assets are 9.172 billion US dollars

  Total assets total USD 23.448 billion

  Total current liabilities are 10.388 billion U.S. dollars

  Non-current liabilities totaling $5.313 billion

  Total liabilities total USD 15.701 billion

  The total net assets are 7.747 billion US dollars.

  Current net assets are 7.747 billion U.S. dollars, and the market value is 6.09 billion U.S. dollars!

  Of course, although the market value is only 6.09 billion US dollars, Cardinal Health Group is a Fortune 500 company in the world, and its sales are directly behind Ford Motor Company.

  In 2008, the turnover was 87.408 billion U.S. dollars

  Operating costs US$83.631 billion

  Operating gross profit 3.77 billion US dollars

  A total of US$2.521 billion in operating expenses

  Net profit is 1.301 billion US dollars.

  Dividends to shareholders are also quite large, basically dividends every year.

  Don’t look at low profits, but it occupies a very large market, basically in a monopoly position in the industry, and has a huge chain of interests.

  Although it is a monopolistic enterprise, the price is not high. It is because the price is not high that other new-born companies dare not enter this industry because there is no profit.

For example, the Coca-Cola Company, a bottle of Coca-Cola, almost does not increase the price, the price is kept to the lowest, to prevent enterprises from entering the market, because the price is low, the profit is low, no company dares to enter the market, even if it enters the market, it can't do Coca-Cola. The company will soon suffer a terrible loss.

  This Cardinal Health Group also operates in the same way. The price is so low that other companies dare not enter the competition.

  Luo Baowen said: “BOSS, the operating cost of Cardinal Health Group is very high. Should we move part of the production line to China, where labor costs are low?”

  Wang Guanxi said, "Give it to the members of the Cardinal family."

  In the future, due to drug problems, the Cardinal Group will pay US$5.6 billion for opioid lawsuits. The problem with drugs is a very terrible thing.

  This requires employees who produce drugs, as well as supervising management. They have extremely high quality and ethical standards, but the cost of such employees is very high.

After thinking about it, Wang Guanxi said: “This Cardinal Group occupies nearly 90% of the hospital medicine and nutritional food market in the United States. Credibility."

  "Do not apply for the drug production line of the Cardinal Group. Move some of the non-core and strict production lines of some group companies."

   "Yes, BOSS" Luo Baowen asked again: "The CEO, do we want to replace it?"

  Currently, the chairman of Cardinal Health Group is Evan Cardinal, and the CEO is also the fate of the Cardinal family.

  Wang Guanxi will arrange the chief financial officer and executive director to join the Cardinal Health Group. This CEO should be replaced.

  Thinking of this, Wang Guanxi opened the mouth and said: "I will take a look at the information of the senior management of Cardinal Health Group."

  “Yes, BOSS” Luo Baowen quickly brought in the senior management information of Cardinal Health Group.

  Chief Information Officer

CFO

  Chief Legal and Compliance Officer

  Executive Vice President of Strategy and Corporate Development-

  Chief Human Resources Officer

  CEO of the medical department

  Pharmaceutical Department Chief Executive Officer

  CEO.

  Wang Guanxi read all these positions, and finally he decided to promote Michael Kaufman, CEO of the pharmaceutical department, as the CEO of Cardinal Health Group.

  The original chief executive who belonged to the Cardinal family was fired.

  Of course, other senior executives of the Cardinal family are still there, but the position of CEO requires talents appointed by Wang Guanxi.

   Soon Michael Kaufman came to Wang Guanxi.

  "BOSS!" Michael Kaufman used to be the president of North America at Pepsi-Cola Company, Pepsi Beverage Company.

   also served as Executive Vice President of Pepsi Bottling Group.

   is also a member of the board of directors of the National City League and a member of the board of directors of Boston College, but the salary is not as high as that of Cardinal Health Group.

  Wang Guanxi said: "Michael Kaufman, you will be the CEO of Cardinal Health Group and concurrently an executive director."

   "Yes, BOSS!" Michael Kaufman was extremely excited. He thought that the position of CEO would fall on other executives, but he did not expect to fall on himself, it was like a pie in the sky.

  The salary of the CEO of Cardinal Health Group is several times higher than the salary of the CEO of the pharmaceutical department.

The two chatted, and Michael Kaufman suddenly said: "BOSS, I plan to relocate part of the production lines of Cardinal Health Group to the coastal area of ​​China, where the labor cost is low, and the cost of basic raw materials is also low. Help Cardinal Health Group to reduce costs and firmly occupy the market share of American hospital drugs"

  Wang Guanxi: "Go ahead, especially the production of masks and the like, all move away from the United States."

   "Yes, BOSS" Michael Kaufman was very excited, and then talked about some of his own strategic plans.

  Wang Guanxi nodded, fairly satisfied with Michael Kaufman.

  The Cardinal Health Group's affairs have been settled, and the next step is to close the short list on the Dow Jones Index.

  After closing the position, we will have another big dip!

  But we still wait for the Cardinal Hedge Fund to sell out first!

  At this time, Wang Guanxi saw a piece of news that was bad for the stock market.

  "The market will open next Monday, this Evan Cardinal is really going to die"

  (End of this chapter)